Human papilloma virus type 16 (HPV-16) and herpes simplex virus type 2 (HSV-2) are human viruses implicated in the development of cancer, in particular cervical cancer. The ability of HSV-2 and HPV-16 to transform early passage human cells was examined in this report. For these studies, gingival fibroblasts were utilized. One gingival cell strain was derived from a normal individual (N-16). The second cell strain was derived from hyperplastic gingival tissue of an epileptic individual (R-30) treated with phenytoin, an antiseizure drug. A common side effect of phenytoin is the induction of gingival overgrowth. R-30 cells contained a stable chromosomal translocation between chromo- 
Introduction
Morphological transformation of primary cells is a multistep phenomenon (reviewed in Bishop, 1985; Stanbridge, 1990) . In this report, the multistep nature of transformation was examined using two primary human cell types derived from gingival tissue. Gingival fibroblasts were obtained from a normal individual (N-16) and an epileptic patient treated with phenytoin (R-30), an anti-seizure drug (Delgado-Escueta et al., 1983) . Approximately 50~ of patients taking this drug have gingival hyperplasia and overgrowth can lead to complete obstruction of teeth (Hassell et al., 1983) . Pseudolymphoma syndrome and Hodgkin's disease are associated with prolonged use of phenytoin (reviewed in Wolf et al., 1985) . This investigation was initiated to determine whether R-30 cells and N-16 cells differ with respect to morphological transformation.
Papillomaviruses are small DNA tumour viruses which induce proliferative lesions of the skin and mucosa (reviewed in zur Hausen, 1977; Pfister, 1984) . Although many of the lesions from human papillomavirus (HPV) infections are benign, infection with specific types of HPV are associated with invasive carcinoma. For example, HPV sequences are present in 80 to 85~ of cervical carcinoma biopsies with HPV types 16 and 18 being the most prevalent (Broker & Botchan, 1986; Durst et al., 1983) . Malignant lesions frequently contain HPV DNA integrated into the cellular genome with only a portion of the viral DNA present (Durst et al., 1985) . Invariably, two viral genes, E6 and E7, are intact and expressed (Matsukura et al., 1986; Pater & Pater, 1985; Seedorf et al., 1987) . It is well established that HPV-16 and HPV-18 can immortalize primary human cells, such as keratinocytes (Durst et al., 1987b; Kaur & McDougall, 1988; Woodworth et al., 1989) and fibroblasts (Pirisi et al., 1987; Watanabe et al., 1989) . The E6 and E7 genes are required for this process (Matlashewski et al., 1987; Munger et al., 1989; Watanabe et al., 1989) . In addition, a recent study demonstrated the presence of HPV-16 and -18 DNA sequences in oral epithelial tissues (YeudaU & Campo, 1991) .
Progression to the malignant phenotype after HPV infection in vivo apparently requires additional cofactors. It has been hypothesized that herpes simplex virus type 2 (HSV-2) cooperates with the oncogenic HPVs to produce a malignant phenotype (zur Hausen, 1983) . HSV-2 is an oncogenic DNA virus spread primarily by sexual contact (Ginsberg, 1980) . Inactivated HSV-2 can also immortalize human cells (epithelial as well as primary fibroblasts) but virus is not recovered (Takahashi & Yamanishi, 1974; Kucera & Gusdon, 1976) . Within the HSV-2 genome there are two unique morphological transforming regions (mtr) designated as mtr II (map unit 0.585 to 0-63) and mtr III (map unit 0.42 to 0.58) (Galloway & McDougall, 1981 ; Jariwalla et al., 1983) . The HSV-2 mtr III contains a minimal transforming fragment (TF) of 486 bp (486 TF) which apparently does not encode an oncogenic protein (Jones et al., 1986) . However, it can function as a complex transcriptional promoter element and therefore transformation is hypothesized to be mediated by altered cellular gene expression (Jones, 1989) .
In this study, we examined whether HPV-16 and HSV-2 can transform primary human cells more efficiently together than individually. Although HPVs do not routinely infect fibroblasts, efficient expression of HPV genes in fibroblasts is achieved because gene expression is regulated by the Moloney murine leukaemia virus (M-MuLV) long terminal repeat (LTR) sequence (Matlashewski et al., 1987) . These studies implied R-30 cells were not immortalized but could be immortalized more efficiently than normal N-16 gingival fibroblasts. Cells transformed by multiple transforming agents contained higher numbers of chromosomes when compared to R-30 cells or HPV-16 immortalized cells. Additionally, retention of HSV-2 DNA sequences was detected in R-30 cells transfected with HPV-16 and HSV-2 DNA but not in cells with HPV-16 alone or the parental R-30 cells. Thus, HSV-2 transforming fragments and the activated H-ras oncogene can have an effect on human cells immortalized by HPV-16.
Methods
Cells andplasmids. The human fibroblast cells, R-30, N-16 and C-l, were obtained from Dr Tom Hassell. These cells were split in 1 : 3 ratios weekly and maintained in Earle's modified Eagle's medium (Sigma) supplemented with 10% foetal bovine serum, penicillin (10 units/ml), and streptomycin (100 ~tg/ml). Plasmid HZIP-16 was obtained from Dr G. Matlashewski and contains the early region of HPV-16 genome flanked by the M-MuLV LTR (Matlashewski et al., 1987) . To construct HZIP-16, the region between BamHI and EcoRI was deleted. HZIP-16 contains M-MuLV LTRs, neomycin resistance gene (NeoR), origins of replication (oris) of simian virus 40 (SV40) and pBR322 vector sequences in addition to the HPV-16 early region. Within the vector sequences, two more EcoRI sites are present (in addition to those within HPV-16 sequences) such that digestion of HZIP-16 with EcoRI yields three bands (9.4 kb, 6-5 kb and 2.5 kb). The 9.4 kb band contains the H PV-I 6 sequences plus vector sequences (data not shown). Plasmid pEJ6.6 containing the Ha-ras oncogene was from ATCC (no. 41028). The HSV-2 plasmids contain various sequences derived from HSV-2 mtr III (Jones et al., 1986) . The 1.6 kb SacI fragment of the 5' untranslated region of c-myc was from ATCC (no. 39286) and plasmid pEX2 containing a 420 bp fragment of exon 2 was obtained from Dr Len Erickson.
Eukaryotic cell transfections. Low passage R-30 cells or N-16 cells were transfected with 25 lag DNA using calcium phosphate precipitation (Graham & Van der Eb, 1973) . A 25 % DMSO shock was used to facilitate uptake of DNA following calcium phosphate precipitation. Seventy-two hours after transfection, the antibiotic geneticin (Sigma) was added to the cultures (400 lag/ml) to select for cells containing plasmids. All cultures were cotransfected with pSV2neo (5 lag/60 mm dish) since the neomycin resistance gene of HZIP-16 was not active. Geneticin selection was carried out for 2 to 3 weeks post-transfection or until all the ceils in the control dish were dead. When densely growing colonies became macroscopic in size, the cells in a 60 mm dish were trypsinized and subcultured as described above in the absence of geneticin. For experiments using a single transforming agent 486 TF, , 20 ~tg of the respective plasmid was added to 5 lag pSV2neo and the mixture was used for transfection. If multiple transforming sequences were used (HZIP-16/ H-ras, , 10 Ixg of each respective plasmid was combined with 5 lag pSV2neo and these mixtures were used for transfections. Anchorage-independent growth was performed as previously described (Jones et al., 1986) .
DNA preparation and Southern blot hybridization. High M r DNA was prepared from mammalian cells (Maniatis et al., 1982) . The respective DNA samples were digested to completion with EcoRI (10 units/ktg) for 16 to 18 h at 37 °C. The digested DNA samples, approximately 10 p.g, were subsequently subjected to electrophoresis in 1.0% agarose gels buffered with Tris-borate (0.089 M-Tris-borate, 0.089 M-boric acid and 0.002 M-EDTA) and the DNA transferred to nitrocellulose (Southern, 1975) . 32p-Labelled probes were prepared by random priming in the presence of [~t-32p]dCTP (1 x 108 c.p.m./lag DNA) and hybridized to the filter in a solution which contained 50% formamide, 5 x SSC, 2 x Denhardt's solution, 50 ~tg/ml sheared salmon sperm DNA, 0.1% SDS and 0.05 M-sodium diphosphate pH 6.8. Hybridization was carried out at 42 °C for 16 h. The filters were washed with 2 x SSC, 0.2% SDS (three times, 20 min each) and subsequently in 0.2 x SSC, 0-5% SDS (three times, 20 min each). All washes were performed at 55 °C. Filters were air-dried and autoradiographed.
RNA extraction and ribonuclease protection analysis. Total cellular RNA was extracted from cells by the method of Peppel & Baglioni (1990) . Cells were washed with PBS and lysed with a solution containing 2% SDS, 200 mM-Tris-HC1 pH 7.5, and I mM-EDTA. DNA and proteins were precipitated from the lysate by addition of 4.37 Mpotassium acetate. The RNA containing supernatant was extracted with phenol :chloroform :isoamyl alcohol (25:24:1) and chloroform:isoamyl alcohol (24:1), the RNA was precipitated with isopropanol, and was stored at -70 °C in formamide.
Ribonuclease protection analysis (RPA) was performed using the RPA kit by Ambion. An in vitro generated RNA probe (7 x 104 c.p.m.
[32p]UTP) was mixed with 10 lag total cellular RNA. Samples were ethanol-precipitated and resuspended in a hybridization buffer (80% formamide, 40 m~I-PIPES pH 6.4, 400 mM-sodium acetate pH 6.4, 1 mM-EDTA) and hybridized overnight at 45 °C. Hybrids were digested with a solution containing RNase A/RNase T1 to digest unprotected ssRNA. SDS and proteinase K were added and subsequently extracted with phenol:chloroform:isoamyl alcohol (25:24:1). The RNAs were precipitated and run on an 8 M-urea/5% acrylamide denaturing gel to separate RNA species. The gel was dried and subjected to autoradiography.
Polymerase chain reaction (PCR) analysis.
High Mr DNA was prepared from various cell lines as previously described and digested with PstI overnight at 37 °C. All transformed cells had undergone at least 80 population doublings (PDs) post-transfection prior to DNA isolation. Oligonucleotide primers (Genosys Biotechnologies), 21 bases in length, were chosen to amplify a target sequence of 366 bp located within the HSV-2 mtr III 486 TF sequence. The primers were synthesized according to the published sequence of HSV-2 mtr III PstI-C fragment (Jones et al., 1986) . Primer 917 contained nucleotides 917 to 937 of the plus strand (5' TCACGGAGGACGACTTTGGGC 3") and primer 1262 contained nucleotides 1262 to 1282 of the minus strand (5' GCGTGTTCGGGGTGCTGTGGA 3"). The probe used to detect the amplified sequence was 486 TF (486 bp Pstl-SalI fragment).
PCR was performed in 100 ktl volumes in standard commercial buffer (Promega) containing 1.5 mM-MgClz. Cycling parameters for PCR were 1 min at 94 °C for denaturation, 1 min of primer annealing at 60 °C and 2 min at 72 °C for extension. A total of 40 cycles was run. For PCR, 1 lag of template DNA was used. Amplification products were analysed on 2% Nu-Sieve 3:1 agarose (FMC Bioproducts) gels containing 1 x TBE buffer and 0.5 ~tg/ml ethidium bromide. Subsequently, Southern blot analysis of the gels was done using random primed 32p-labelled 486 TF probes. Prehybridization was for 1 h at 61 °C in 5 x SSPE (1 x SSPE contains 0.18 M-NaC1, 0"01 M-sodium phosphate, 1 mM-disodium EDTA pH 7.7), 5 × Denhardt's and 1 SDS. Blots were hybridized in the prehybridization solution which contained the denatured probe. Filters were washed in 1 x SSPE and 1% SDS three times at room temperature and once at 65 °C. Precautions were taken to avoid DNA carryover. Isolation of pretarget and post-target DNA was done in physically different areas, disposable labware and positive displacement pipettes were used for all DNA manipulations, and protective covering for clothing, hair and face was used. Positive control for all PCRs was a plasmid, pCPS-I (486 TF cloned into PstI and Sail sites of pUCI9) (Jones et aL, 1986) .
Negative controls for the PCRs were DNA from normal cells and the 'no template' reactions which contained all components of the PCR reaction except for the template. 'No template' lanes provided a control for PCR performance.
Results

Transfection analysis
To test for morphological transformation of R-30 and N-16 cells, a plasmid containing the early genes of HPV-16, HZIP-16 (Matlashewski et al., 1987) (Fig. 1) , was transfected either alone or in combination with plasmids containing HSV-2 sequences derived from morphological transforming region III, mtr III (Jones et al., 1986) , into the respective cell lines. In addition, a plasmid containing an activated H-ras gene, pEJ6.6, was cotransfected with HZIP-16 to serve as a positive control for cooperation with HPV-16. Matlashewski et al. (1987) demonstrated HPV-16 and H-ras could cooperate to transform primary cells. Table 1 shows the results from the transfection experiments using N-16 and R-30 parental cells. Phenytoin-treated cells (R-30) were more susceptible to immortalization by HZIP-16 alone in comparison to fibroblasts from a normal individual (N-16). These differences were not merely due to higher levels of plasmid DNA uptake in R-30 cells since both cell types contained similar levels of DNA at 48 h posttransfection (data not shown). When H-ras, an activated cellular oncogene, was transfected into R-30 cells or N-16 (Newbold & Overell, 1983; Sager et al., 1983) , it appears that R-30 and N-16 cells do not behave like immortalized 
Retention of viral DNA in transformed cells
The various cell lines were analysed to detect retention of transfected DNA. HPV-16 DNA is generally integrated in malignant lesions in vivo (Durst et al., 1985) and thus it was of interest to assess the presence of HPV-16 DNA sequences in transformed cell lines. When an EcoRI digest of genomic DNA was probed with HPV-16 DNA, it was evident that all transformed cell lines retained HPV-16 DNA (Fig. 2) . In all cell lines except cell line 139, a 9.4 kb HPV-specific hybridizing band was detected. Minor bands which also hybridized to the HPV probe were detected in cell line 140 (7.5 kb band) and cell line 145 (7.9 kb). In cell line 139 two HPV-specific bands (12.5 kb and 6-4 kb) were detected. Since a recent report demonstrated that HPV-16 can be detected in oral epithelial tissue (YeudaU & Campo, 1991) , it was important to determine whether HPV-16 sequences were (1353, 1078, 872, 603, 310, 281, 234, 174 and 118 bp).
The retention of HSV-2 DNA sequences in transformed cells was examined by PCR. The stable retention of HSV-2 D N A in transformed cells has not been consistently observed and thus HSV-2 transformation has been postulated to be mediated by a hit and run mechanism (reviewed by Macnab, 1986 ). Southern blot analysis using HSV-2 D N A sequences as probes failed to detect HSV-2 DNA (data not shown). However, when high Mr D N A was subjected to PCR analysis using primers derived from 486 TF, retention of HSV-2 D N A was detected in three cell lines. All three had been transfected with HSV-2 D N A sequences: (i) cell line 140 ( H Z I P -1 6 + H S V -2 486 TF), (ii) cell line 141 ( H Z I P -1 6 + H S V -2 BgllI-C) and (iii) cell line 268 (HZIP-16 + HSV-2 BamHI-E) (Fig. 3) 
Chromosome analysis of transformed cells
To examine the chromosomal composition of the various cell lines, karyotype analysis was performed. Only 50~o of the cells transfected with HZIP-16 alone (145) were aneuploid and none of the aneuploid cells contained more than 100 chromosomes. However, 90~o of the cells derived from lines cotransfected with HZIP-16 and HSV-2 DNA (140 and 141) were aneuploid (Table 2) t Saturation density was the number of cells/100 m m dish at confluence. Plates were seeded with 3 x l0 s cells and the various cultures were fed two times a week. After two weeks in culture, the cells were trypsinized and counted using a haemocytometer. Values are the average of three independent experiments. HZIP-16 alone (145) was lower than cells cotransfected with HZIP-16/HSV-2 or HZIP-16/H-ras. When the individual cell lines were injected subcutaneously into nude mice (5 × 106 t o 8 × 106 cells/animal), tumour formation was not readily observed after 6 weeks (data not shown). Transitory nodules were observed in animals injected with some of the transformed cells. However, these nodules regressed after several weeks. This may imply the cell lines were not fully transformed or that the transformed cells were rejected by the mouse. In summary, anchorage-independent growth was more efficient when R-30 cells were cotransfected with HZIP-16 and HSV-2 D N A sequences or H-ras.
Comparison of N-16 and R-30 cells
Since R-30 cells were immortalized more efficiently by HZIP-16 than by N-16 cells, a comparison of the two cell types was subsequently made. No obvious differences were detected in morphological characteristics [fluorescence-activated cell sorting (FACS), 90 ° versus forward scattering ratios], growth rates, or saturation densities (data not shown). In contrast, karyotype analysis of the two cell types revealed that all R-30 cells have a stable chromosomal translocation between chromosome 8 and chromosome 18 (Fig. 4) . Approximately 15% of R-30 cells contained more than 50 chromosomes. Only 5% of N-16 cells contained more than 50 chromosomes.
Since the c-myc protooncogene is present on chromosome 8 (Neel et al., 1982) and alterations of this gene have been associated with HPV-16 and transformation (Riou et al., 1987; Durst et al., 1987 a; Crook et al., 1990) (Jariwalla et al., 1983) , it could not immortalize R-30 cells by itself. This suggests that requirements for immortalizing human cells are unique with respect to primary rodent cells. When HPV-16 containing plasmids were cotransfected with H-ras or HSV-2 D N A sequences, the resulting cell lines grew more efficiently in soft agar, had a higher saturation density and were more aneuploid when compared to R-30 cells or R-30 cells immortalized by HPV-16. The finding that HPV-16 was able to immortalize the hyperplastic R-30 cells more efficiently than N-16 cells implied R-30 cells may be predisposed toward malignant transformation. It is tempting to speculate that the chromosomal translocation in R-30 cells and overexpression of c-myc plays a role in efficient immortalization by HPV-16. Southern blot analysis using two c-myc probes (Y-untranslated region and a portion of exon 2) showed no major differences in c-myc D N A organization. However, c-myc gene expression in R-30 cells and R-30 derived cell lines was two-to threefold higher when compared to N-16 or C-1 (cyclosporin-treated) cells. Both of these primary cell strains do not contain obvious chromosomal aberrations. Integration of papillomavirus sequences near the c-myc locus has been hypothesized to play a role in viral transformation (Durst et al., 1987a) and as such c-myc appears to play a role in HPV-induced transformation. Although c-myc is slightly overexpressed in R-30 cells, the increased levels of c-myc was apparently not sufficient to allow H-ras to transform R-30 cells as described using cotransfection experiments with an activated c-myc and H-ras (Land et al., 1983; Parada et al., 1984) . It is not known whether the chromosomal translocation in R-30 cells is a common result of phenytoin treatment. Phenytoin treatment of epileptic patients clearly leads to hyperplastic gingival growth (Hassel et al., 1983) and may be related to an increased incidence of pseudolymphoma syndrome and Hodgkin's disease (reviewed in Wolf et al., 1985) . Apart from these observations, little is known concerning the deleterious side effects of prolonged use of phenytoin. Thus, it appears cellular factors can play a crucial role in the efficiency of HZIP-16-induced immortalization of early passage human cells.
Hyperplastic R-30 cells could be a unique model to study multistep carcinogenesis since they do not behave as a typical immortalized cell line. This conclusion is based on the fact that H-ras alone or HSV-2 transforming fragments were unable to stably transform R-30 cells (Table 1) . Several studies have demonstrated that H-ras can transform established or immortalized cells but not primary human or rodent cells (Sager et al., 1983; Barbacid, 1987 and references therein) . When H-ras or HSV-2 DNA fragments were cotransfected with HZIP-16, the resulting cell lines were distinct when compared to cells immortalized by HZIP-16. For instance, cotransfection of HZIP-16 with H-ras or HSV-2 DNA sequences consistently led to a higher degree of aneuploidy and these cells also grew better in soft agar when compared to HZIP-16-immortalized R-30 cells. In summary, DNA sequences derived from HSV-2 mtr III or H-ras played a role in efficient growth of R-30 cells when cotransfected with HZIP-16.
The mechanism by which a cell progresses to the malignant phenotype after HPV-16 infection in vivo is not known. The presence of HPV-16 or HPV-18 alone is usually not sufficient for tumorigenesis (reviewed in Broker & Botchan, 1986) . Additional cofactors, environmental or viral, may play a crucial role in tumour progression events. In fact, progression may be mediated by infection with another virus, HSV-2 (zur Hausen, 1983) . A recent study demonstrated by Southern blot analysis that 16.7~ of invasive cervical carcinoma biopsies which hybridized to HPV-16 also hybridized to HSV-2 mtr III DNA sequences, BamHI-E (Di Luca et al., 1989) .
In our analysis, HSV-2 DNA sequences derived from mtr III were present in each of the three cell lines cotransfected with HZIP-16 and mtr III containing plasmids (cell lines 140, 141 and 268; Fig. 3 ). These results suggested retention of HSV-2 DNA sequences may lead to aberrant growth characteristics of R-30 cells in soft agar compared to R-30 cells immortalized with HZIP-16 alone. It is not clear whether HSV-2 DNA sequences are integrated or persist as an episome in these cells; however, these cells have undergone extensive passage (at least 80 PD post-geneticin selection) prior to PCR analysis. Experiments to address the physical state and stability of HSV-2 sequences are currently in progress. It appears HSV-2 DNA sequences derived from mtr III were consistently retained in R-30 cells and can have a profound effect on R-30 cells when cotransfected with HZIP-16.
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